Home Merck Sues Actavis Unit Over Patent for Generic NuvaRing
 

Keywords :   


Merck Sues Actavis Unit Over Patent for Generic NuvaRing

2013-12-25 00:26:03| Biotech - Topix.net

Merck & Co. sued Actavis Plc's Warner Chilcott unit seeking to block sales of a generic version of NuvaRing, a contraceptive with estimated annual sales of more than $664 million.

Tags: unit patent generic merck

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
26.06Horizon expert 'gave evidence based on informal chats'
26.06Automotive Color by BASF Recognized with Renowned Red Dot Award
26.06Beckers Commits to Widespread Science Based Targets
26.06PPG to Announce Second-quarter 2024 Results July 18
26.06Fresh Coat for First Responders: New Hampshire Fire Station Gets a Makeover by California Paints
26.06Michigan Sets Record Recycling Rate in 2023, Recycles Nearly 70,000 Tons of Materials
26.06Companies Seek Federal EPR: How Producers Can Prepare
26.06Q&A with GFLs Tyler Stefure: Integrating New Fleet Tech & Upholding GFL Values
More »